These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17762567)

  • 1. Management of peripheral T-cell non-Hodgkin's lymphoma.
    Horwitz SM
    Curr Opin Oncol; 2007 Sep; 19(5):438-43. PubMed ID: 17762567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation in the treatment of peripheral T-cell lymphomas.
    Majhail NS; Burns LJ
    Curr Hematol Rep; 2005 Jul; 4(4):252-9. PubMed ID: 16009039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of peripheral T-cell lymphomas.
    O'leary H; Savage KJ
    Curr Opin Hematol; 2009 Jul; 16(4):292-8. PubMed ID: 19509496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review.
    Rodriguez-Abreu D; Filho VB; Zucca E
    Hematol Oncol; 2008 Mar; 26(1):8-20. PubMed ID: 18050364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral T-cell lymphomas.
    Savage KJ
    Blood Rev; 2007 Jul; 21(4):201-16. PubMed ID: 17512649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.
    Rodríguez J; Gutiérrez A; Martínez-Delgado B; Perez-Manga G
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):181-98. PubMed ID: 19056295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of single-agent purine analogues in therapy of peripheral T-cell lymphomas.
    Dearden CE
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S22-6. PubMed ID: 16549111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapies for peripheral T-cell non-Hodgkin's lymphomas.
    Cheson BD
    Curr Opin Hematol; 2009 Jul; 16(4):299-305. PubMed ID: 19367159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
    Sohn BS; Park I; Kim EK; Yoon DH; Lee SS; Kang BW; Jang G; Choi YH; Kim C; Lee DH; Kim S; Huh J; Suh C
    Bone Marrow Transplant; 2009 Sep; 44(5):287-93. PubMed ID: 19234508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management of T-cell malignancies: current perspectives, key issues, and emerging therapies.
    Cheson BD
    Semin Oncol; 2007 Dec; 34(6 Suppl 5):S3-7. PubMed ID: 18086345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral T-cell lymphomas.
    Macon WR
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):829-42. PubMed ID: 19577171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
    Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
    Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
    Le Gouill S; Milpied N; Buzyn A; De Latour RP; Vernant JP; Mohty M; Moles MP; Bouabdallah K; Bulabois CE; Dupuis J; Rio B; Gratecos N; Yakoub-Agha I; Attal M; Tournilhac O; Decaudin D; Bourhis JH; Blaise D; Volteau C; Michallet M;
    J Clin Oncol; 2008 May; 26(14):2264-71. PubMed ID: 18390969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome.
    Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M
    Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current state of art for transplantation paradigms in peripheral T-cell lymphomas.
    Perrone G; Farina L; Corradini P
    Expert Rev Hematol; 2013 Aug; 6(4):465-74. PubMed ID: 23991932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
    Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
    Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategies for peripheral T-cell lymphomas.
    Foss FM
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):43-56. PubMed ID: 23768640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
    Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications.
    Dunleavy K; Wilson WH; Jaffe ES
    Curr Opin Hematol; 2007 Jul; 14(4):348-53. PubMed ID: 17534160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel targeted therapies in peripheral T cell lymphoma.
    Jagadeesh D; Smith MR
    Discov Med; 2013 Jun; 15(85):367-78. PubMed ID: 23819951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.